Other Species / Isoforms
  RALBP1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T9-p
TECFLPPtSsPsEHR
0 2
RALBP1 (human) TECFLPPtSsPsEHR T9-p
RALBP1 (mouse) TECFLPPSSsPsEHR S9
RALBP1 (rat) TECFLPPTSsPSEHR T9
S11-p
CFLPPtSsPsEHRRV
0 9
RALBP1 (human) CFLPPtSsPsEHRRV S11-p
RALBP1 (mouse) CFLPPSSsPsEHRRA S11-p
RALBP1 (rat) CFLPPTSsPSEHRRA S11-p
S13-p
LPPtSsPsEHRRVEH
0 3
RALBP1 (human) LPPtSsPsEHRRVEH S13-p
RALBP1 (mouse) LPPSSsPsEHRRAEH S13-p
RALBP1 (rat) LPPTSsPSEHRRAEH S13
S22-p
HRRVEHGsGLtRtPs
0 3
RALBP1 (human) HRRVEHGsGLtRtPs S22-p
RALBP1 (mouse) HRRAEHGsGLtRtPs S22-p
RALBP1 (rat) HRRAEHGSGLTRtPs S22
T25-p
VEHGsGLtRtPssEE
0 3
RALBP1 (human) VEHGsGLtRtPssEE T25-p
RALBP1 (mouse) AEHGsGLtRtPssEE T25-p
RALBP1 (rat) AEHGSGLTRtPssEE T25
T27-p
HGsGLtRtPssEEIs
0 49
RALBP1 (human) HGsGLtRtPssEEIs T27-p
RALBP1 (mouse) HGsGLtRtPssEEIs T27-p
RALBP1 (rat) HGSGLTRtPssEEIS T27-p
S29-p
sGLtRtPssEEIsPt
Upstream
0 538
Treatment
  • ischemia
RALBP1 (human) sGLtRtPssEEIsPt S29-p
RALBP1 (mouse) sGLtRtPssEEIsPT S29-p
RALBP1 (rat) SGLTRtPssEEISPT S29-p
S30-p
GLtRtPssEEIsPtK
0 103
RALBP1 (human) GLtRtPssEEIsPtK S30-p
RALBP1 (mouse) GLtRtPssEEIsPTK S30-p
RALBP1 (rat) GLTRtPssEEISPTK S30-p
S34-p
tPssEEIsPtKFPGL
Upstream
0 76
Treatment
  • ischemia
RALBP1 (human) tPssEEIsPtKFPGL S34-p
RALBP1 (mouse) tPssEEIsPTKFPGL S34-p
RALBP1 (rat) tPssEEISPTKFPEL S34
T36-p
ssEEIsPtKFPGLYR
0 4
RALBP1 (human) ssEEIsPtKFPGLYR T36-p
RALBP1 (mouse) ssEEIsPTKFPGLYR T36
RALBP1 (rat) ssEEISPTKFPELYR T36
T44-p
KFPGLYRtGEPsPPH
0 1
RALBP1 (human) KFPGLYRtGEPsPPH T44-p
RALBP1 (mouse) KFPGLYRTGEPsPPH T44
RALBP1 (rat) KFPELYRTGEPsPPH T44
S48-p
LYRtGEPsPPHDILH
Upstream
0 57
Treatment
  • dasatinib
RALBP1 (human) LYRtGEPsPPHDILH S48-p
RALBP1 (mouse) LYRTGEPsPPHDVLH S48-p
RALBP1 (rat) LYRTGEPsPPHDILH S48-p
V60
ILHEPPDVVsDDEKD
0 2
RALBP1 (human) ILHEPPDVVsDDEKD V60
RALBP1 (mouse) VLHEPPDtVsDDDKD T60-p
RALBP1 (rat) ILHEPPDIVsDDEKD I60
S62-p
HEPPDVVsDDEKDHG
Upstream
0 59
Treatment
  • dasatinib
  • EGF
RALBP1 (human) HEPPDVVsDDEKDHG S62-p
RALBP1 (mouse) HEPPDtVsDDDKDHG S62-p
RALBP1 (rat) HEPPDIVsDDEKDHG S62-p
T82-p
FKKKEKRtEGyAAFQ
0 2
RALBP1 (human) FKKKEKRtEGyAAFQ T82-p
RALBP1 (mouse) FKKKEKRtEGyAAFQ T82-p
RALBP1 (rat) FKKKEKRTEGYVAFQ T82
Y85-p
KEKRtEGyAAFQEDs
0 2
RALBP1 (human) KEKRtEGyAAFQEDs Y85-p
RALBP1 (mouse) KEKRtEGyAAFQEDs Y85-p
RALBP1 (rat) KEKRTEGYVAFQEDS Y85
S92-p
yAAFQEDssGDEAEs
0 41
RALBP1 (human) yAAFQEDssGDEAEs S92-p
RALBP1 (mouse) yAAFQEDssGDEAEs S92-p
RALBP1 (rat) YVAFQEDSsGDEAES S92
S93-p
AAFQEDssGDEAEsP
0 45
RALBP1 (human) AAFQEDssGDEAEsP S93-p
RALBP1 (mouse) AAFQEDssGDEAEsP S93-p
RALBP1 (rat) VAFQEDSsGDEAESP S93-p
S99-p
ssGDEAEsPSKMKRS
0 5
RALBP1 (human) ssGDEAEsPSKMKRS S99-p
RALBP1 (mouse) ssGDEAEsPSKVKRS S99-p
RALBP1 (rat) SsGDEAESPSKMKRS S99
K107
PSKMKRSKGIHVFKK
0 1
RALBP1 (human) PSKMKRSKGIHVFKK K107
RALBP1 (mouse) PSKVKRSkGIHVFkK K107-ac
RALBP1 (rat) PSKMKRSKGIHVFKK K107
K113
SKGIHVFKKPsFsKK
0 1
RALBP1 (human) SKGIHVFKKPsFsKK K113
RALBP1 (mouse) SkGIHVFkKPsFSkK K113-ac
RALBP1 (rat) SKGIHVFKKPSFSKK K113
S116-p
IHVFKKPsFsKKKEK
Upstream
0 9
Treatment
  • nocodazole
RALBP1 (human) IHVFKKPsFsKKKEK S116-p
RALBP1 (mouse) IHVFkKPsFSkKKEK S116-p
RALBP1 (rat) IHVFKKPSFSKKKEK S116
S118-p
VFKKPsFsKKKEKDF
Upstream
1 3
Kinase, in vitro:
  • PKCA (human)
RALBP1 (human) VFKKPsFsKKKEKDF S118-p
RALBP1 (mouse) VFkKPsFSkKKEKDF S118
RALBP1 (rat) VFKKPSFSKKKEKDF S118
K119
FKKPsFsKKKEKDFK
0 1
RALBP1 (human) FKKPsFsKKKEKDFK K119
RALBP1 (mouse) FkKPsFSkKKEKDFK K119-ac
RALBP1 (rat) FKKPSFSKKKEKDFK K119
S151-p
EKHKEKKskDLTAAD
0 1
RALBP1 (human) EKHKEKKskDLTAAD S151-p
RALBP1 (mouse) EKHKEKKSKDLTAAD S151
RALBP1 (rat) EKHKEKKCKDFTAAD C151
K152-ub
KHKEKKskDLTAADV
0 1
RALBP1 (human) KHKEKKskDLTAADV K152-ub
RALBP1 (mouse) KHKEKKSKDLTAADV K152
RALBP1 (rat) KHKEKKCKDFTAADV K152
K161-ub
LTAADVVkQWKEKKK
0 2
RALBP1 (human) LTAADVVkQWKEKKK K161-ub
RALBP1 (mouse) LTAADVVKQWKEKKK K161
RALBP1 (rat) FTAADVVKQWKEKKK K161
K187
QIDVPNLKPIFGIPL
0 7
RALBP1 (human) QIDVPNLKPIFGIPL K187
RALBP1 (mouse) QMDAPSVkPIFGVPL K187-ub
RALBP1 (rat) QTDAPSLRPIFGAPF R187
Y219-p
VFRECIDyVEKYGMK
0 1
RALBP1 (human) VFRECIDyVEKYGMK Y219-p
RALBP1 (mouse) VFRECVDYMEKHGMK Y219
RALBP1 (rat) VFRECVDYMEKHGMK Y219
S234-p
CEGIYRVsGIKSKVD
0 2
RALBP1 (human) CEGIYRVsGIKSKVD S234-p
RALBP1 (mouse) CEGVYRVSGIKSKVD S234
RALBP1 (rat) CEGIYRVSGIKSKVD S234
S252-p
AAYDREEstNLEDYE
0 1
RALBP1 (human) AAYDREEstNLEDYE S252-p
RALBP1 (mouse) AAYDREESPNLEEYE S252
RALBP1 (rat) AAYDREESPNLEEYE S252
T253-p
AYDREEstNLEDYEP
0 1
RALBP1 (human) AYDREEstNLEDYEP T253-p
RALBP1 (mouse) AYDREESPNLEEYEP P253
RALBP1 (rat) AYDREESPNLEEYEP P253
K268-ub
NTVASLLkQyLRDLP
0 1
RALBP1 (human) NTVASLLkQyLRDLP K268-ub
RALBP1 (mouse) NTVASLLKQYLRDLP K268
RALBP1 (rat) NTVASLLKQYLRDLP K268
Y270-p
VASLLkQyLRDLPEN
0 1
RALBP1 (human) VASLLkQyLRDLPEN Y270-p
RALBP1 (mouse) VASLLKQYLRDLPEN Y270
RALBP1 (rat) VASLLKQYLRDLPEN Y270
T280-p
DLPENLLtkELMPRF
0 1
RALBP1 (human) DLPENLLtkELMPRF T280-p
RALBP1 (mouse) DLPENLLTKELMPRF T280
RALBP1 (rat) DLPENLLTKELMPRF T280
K281-ub
LPENLLtkELMPRFE
0 1
RALBP1 (human) LPENLLtkELMPRFE K281-ub
RALBP1 (mouse) LPENLLTKELMPRFE K281
RALBP1 (rat) LPENLLTKELMPRFE K281
T297-p
ACGRTTEtEkVQEFQ
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
  • protein conformation
Kinase, in vitro:
  • PKCA (human)
RALBP1 (human) ACGRTTEtEkVQEFQ T297-p
RALBP1 (mouse) ACGKTTEMEKVQEFQ M297
RALBP1 (rat) ACGRTTEVEKVQEFQ V297
K299-ub
GRTTEtEkVQEFQRL
0 1
RALBP1 (human) GRTTEtEkVQEFQRL K299-ub
RALBP1 (mouse) GKTTEMEKVQEFQRL K299
RALBP1 (rat) GRTTEVEKVQEFQRL K299
S353-p
LSPTVQIsNRVLYVF
Upstream
1 0
Kinase, in vitro:
  • PKCA (human)
RALBP1 (human) LSPTVQIsNRVLYVF S353-p
RALBP1 (mouse) LSPTVQISNRVLYVL S353
RALBP1 (rat) LSPTVQISNRVLYVL S353
K421-ub
RDLQGGIkDLSKEER
0 1
RALBP1 (human) RDLQGGIkDLSKEER K421-ub
RALBP1 (mouse) RDLQGGIKDLSKEER K421
RALBP1 (rat) RDLQGGIKDFSKEER K421
K454-ub
KRQECETkIAQEIAs
0 1
RALBP1 (human) KRQECETkIAQEIAs K454-ub
RALBP1 (mouse) KRQECETKIAQEIAs K454
RALBP1 (rat) KRQECETKIAQEIAS K454
S461-p
kIAQEIAsLsKEDVS
0 10
RALBP1 (human) kIAQEIAsLsKEDVS S461-p
RALBP1 (mouse) KIAQEIAsLsKEDVS S461-p
RALBP1 (rat) KIAQEIASLsKEDVS S461
S463-p
AQEIAsLsKEDVSkE
Upstream
0 36
Treatment
  • dasatinib
RALBP1 (human) AQEIAsLsKEDVSkE S463-p
RALBP1 (mouse) AQEIAsLsKEDVSKE S463-p
RALBP1 (rat) AQEIASLsKEDVSKE S463-p
K469-ub
LsKEDVSkEEMNENE
0 1
RALBP1 (human) LsKEDVSkEEMNENE K469-ub
RALBP1 (mouse) LsKEDVSKEEMNENE K469
RALBP1 (rat) LsKEDVSKEETNENE K469
S509-p
FLRRQIAsEKEEIER
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • PKCA (human)
RALBP1 (human) FLRRQIAsEKEEIER S509-p
RALBP1 (mouse) FLRRQIASEKEEIDR S509
RALBP1 (rat) FLRRQIASEKEEIDR S509
K600-ub
LLQMQRAkAEQQAQE
0 1
RALBP1 (human) LLQMQRAkAEQQAQE K600-ub
RALBP1 (mouse) LLQMQRAKSEQQPQE K600
RALBP1 (rat) LLQMLRAKSEQQLQE K599
S645-p
GKEPAKPsPsRDRKE
0 14
RALBP1 (human) GKEPAKPsPsRDRKE S645-p
RALBP1 (mouse) AKEQAKASPSKDRKE S638
RALBP1 (rat) AKEQAKPSPSKDRKE S637
S647-p
EPAKPsPsRDRKETS
0 1
RALBP1 (human) EPAKPsPsRDRKETS S647-p
RALBP1 (mouse) EQAKASPSKDRKETP S640
RALBP1 (rat) EQAKPSPSKDRKETP S639